# Research suggests cannabis use may impact sperm count, motility, morphology, and overall … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/research-suggests-cannabis-use-may-impact-sperm-count-motility-morphology-and-overall/ > **Published:** 2026-06-01T21:37:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:53:45-04:00 > **Clinical Summary:** Cannabis use may alter sperm count, motility, and morphology. Evidence and clinical counseling for men planning conception. --- ✦ New CED Clinical Relevance #35 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchSafetyTHCReproductive Health[Male Fertility](https://cedclinic.com/cannabinoid-receptors-sperm-maturation-quality/)IVFCannabis Effects Why This Matters Clinicians should counsel male patients planning pregnancy that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) may impair sperm parameters including count, motility, and morphology, potentially reducing fertility outcomes. This evidence is particularly relevant for reproductive medicine specialists and primary care providers discussing family planning with male patients. Patients seeking fertility treatment should be informed about cannabis’s potential impact on semen quality so they can make informed decisions about use before conception. Clinical Summary Recent evidence indicates that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) may adversely affect [male fertility](https://cedclinic.com/cannabinoid-receptors-sperm-maturation-quality/) parameters including sperm count, motility, and morphology, with a 2024 case-control study of IVF patients providing robust data supporting this association. These findings are particularly relevant for clinicians counseling male patients of reproductive age who are using or considering cannabis, as the effects on spermatogenesis could impact fertility outcomes and family planning timelines. The mechanisms underlying these reproductive effects likely involve cannabinoid-mediated disruption of endocrine signaling and testicular function, though further research is needed to establish dose-response relationships and reversibility following cessation. Clinicians should incorporate reproductive history and fertility goals into cannabis risk-benefit discussions with male patients, especially those presenting with infertility or planning conception. Male patients using cannabis who are experiencing difficulty conceiving should be counseled about potential fertility impacts and offered reproductive assessment. Practitioners caring for couples pursuing assisted reproductive technologies should specifically screen male partners for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and discuss the potential implications for treatment success. Dr. Caplan’s Take “We have sufficient evidence now that cannabis use meaningfully affects [male fertility](https://cedclinic.com/cannabinoid-receptors-sperm-maturation-quality/) parameters, and I counsel patients planning conception that stopping use several months before attempting pregnancy gives them the best chance of success, particularly when morphology or motility are already borderline concerns.” Clinical Perspective Emerging evidence from controlled studies suggests that cannabis use may adversely affect multiple parameters of male fertility, including sperm count, motility, and morphology, which warrants clinical attention given the increasing prevalence of cannabis use among reproductive-age men. However, several important confounders limit current interpretability: most studies are observational or involve small sample sizes, the dose-response relationship remains unclear, duration and recency of use are often poorly characterized, and cannabis products vary widely in cannabinoid composition and [route of administration](https://cedclinic.com/state-ban-smokable-cannabis-impact-central-texas/). Additionally, many men using cannabis concurrently use tobacco, alcohol, or other substances that independently affect spermatogenesis, making it difficult to isolate cannabis’s specific contribution. Given these uncertainties, clinicians should consider obtaining a detailed cannabis use history as part of routine fertility counseling for couples with male factor infertility or unexplained subfertility, and may counsel men with fertility concerns that current evidence suggests potential 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Research%20suggests%20cannabis%20use%20may%20impact%20sperm%20count%2C%20motility%2C%20morphology%2C%20and%20overall%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57198)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57198)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Research%20suggests%20cannabis%20use%20may%20impact%20sperm%20count%2C%20motility%2C%20morphology%2C%20and%20overall%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D57198)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Does Weed Really Lower Testosterone? – VICE](https://cedclinic.com/does-weed-really-lower-testosterone-vice/) - [Cannabis use does not lower testosterone, suggests study – Medical Dialogues](https://cedclinic.com/cannabis-use-does-not-lower-testosterone-suggests-study-medical-dialogues/) - [Cannabis use does not lower testosterone, study concludes – Medical Xpress](https://cedclinic.com/cannabis-use-does-not-lower-testosterone-suggests-study-medical-dialogues/) 📰 Source: [https://www.instagram.com/reel/DZD8yXjJnrH/](https://www.instagram.com/reel/DZD8yXjJnrH/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).